Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prebiotic modulation of FMT donor microbiota enhances MASLD-relevant taxa and functions in an in vitro gut model.

Journal of applied microbiology·2026
Same author

Multi-Species Synbiotic Supplementation After Antibiotics Promotes Recovery of Microbial Diversity and Function, and Increases Gut Barrier Integrity: A Randomized, Placebo-Controlled Trial.

Antibiotics (Basel, Switzerland)·2026
Same author

Multi-Species Synbiotic Supplementation Enhances Gut Microbial Diversity, Increases Urolithin A and Butyrate Production, and Reduces Inflammation in Healthy Adults: A Randomized, Placebo-Controlled Trial.

Nutrients·2025
Same author

Probiotic effects on ectoparasitic mite infestations in honey bees (<i>Apis mellifera</i>) are modulated by environmental conditions and route of administration.

Microbiology spectrum·2025
Same author

The impact of progressive chronic kidney disease on hepatic drug metabolism.

Drug metabolism and disposition: the biological fate of chemicals·2025
Same author

Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial.

PloS one·2025
Same journal

Mapping the genomic landscape of two key human gut microbial species: <i>Bifidobacterium infantis</i> and <i>Bifidobacterium longum</i>.

Microbiome research reports·2026
Same journal

Therapeutic potential of <i>Lachnospiraceae</i> strains in irritable bowel syndrome via differential gut-brain pathways.

Microbiome research reports·2026
Same journal

Immunoglobulin Y protects intestinal epithelium and modulates gut microbiota.

Microbiome research reports·2026
Same journal

Intestinal mucus acts as a nutrient source and signal for <i>Klebsiella pneumoniae</i>.

Microbiome research reports·2026
Same journal

Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.

Microbiome research reports·2026
Same journal

Bacterial clusters are associated with the risk of severe disease progression in inflammatory bowel disease irrespective of conventional disease categories.

Microbiome research reports·2026
See all related articles

Related Experiment Video

Updated: Jul 9, 2025

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
07:34

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

8.2K

Perspective: microbial interventions in the urinary tract.

Gregor Reid1,2

  • 1Canadian R&D Centre for Human Microbiome and Probiotics, Lawson Health Research Institute, London, Ontario N6A 4V2, Canada.

Microbiome Research Reports
|December 4, 2023
PubMed
Summary
This summary is machine-generated.

Urinary tract infection (UTI) prevention in women has stalled, with antibiotics being the main treatment. Research into probiotics shows promise for preventing recurrent UTIs and urological issues, but more evidence is needed.

Keywords:
Urinary tractbeneficial microbescalculiinfectionprobiotics

More Related Videos

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:56

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

104
Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.1K

Related Experiment Videos

Last Updated: Jul 9, 2025

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
07:34

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

8.2K
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:56

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

104
Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.1K

Area of Science:

  • Urology
  • Microbiology
  • Infectious Diseases

Background:

  • Urinary tract infections (UTIs) are a common health issue for women, with management strategies largely unchanged for decades.
  • Current prevention relies on low-dose antibiotics, but alternative methods are being explored due to limited success and antibiotic resistance concerns.

Purpose of the Study:

  • To provide a perspective on the current status of using beneficial microbes, specifically probiotics, for preventing UTIs in women.
  • To highlight the need for further research and outline recommendations for developing effective novel probiotic therapies for urological conditions.

Main Methods:

  • This perspective synthesizes existing research on probiotics for UTI prevention.
  • It reviews the historical context and current evidence base for microbial interventions in urological health.
  • Recommendations are proposed for future research directions and therapeutic development.

Main Results:

  • While promising studies exist, larger patient groups are required to validate specific probiotic strains for UTI prevention.
  • The role of beneficial microbes in reducing the risk of UTIs and urolithiasis is an active area of research.
  • Current evidence is insufficient to recommend probiotics as a primary preventive regimen for UTIs.

Conclusions:

  • Novel probiotic therapies hold potential for managing recurrent UTIs and other urological diseases.
  • Further rigorous clinical trials are essential to identify effective probiotic strains and establish their efficacy.
  • Developing targeted probiotic interventions could offer a valuable alternative or adjunct to antibiotic prophylaxis.